Patent details

EP3544601 Title: A COMPOSITION COMPRISING A BENZAMIDE AND A TNFRSF AGONIST BINDING TO 4-1BB OR GITR, AND THE USE THEREOF IN THE TREATMENT OF CANCER.

Basic Information

Publication number:
EP3544601
PCT Application Number:
US2017063195
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178750352
PCT Publication Number:
WO2018098401
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A COMPOSITION COMPRISING A BENZAMIDE AND A TNFRSF AGONIST BINDING TO 4-1BB OR GITR, AND THE USE THEREOF IN THE TREATMENT OF CANCER.
French Title of Invention:
COMPOSITION COMPRENANT UN BENZAMIDE ET UN AGONISTE DU TNFRSF SE LIANT À 4-1BB OU GITR, ET SON UTILISATION DANS LE TRAITEMENT DU CANCER.
German Title of Invention:
EINE ZUSAMMENSETZUNG, DIE EIN BENZAMID UND EINEN TNFRSF-AGONISTEN UMFASST, DER AN 4-1BB ODER GITR BINDET, UND DIE VERWENDUNG DERSELBEN BEI DER BEHANDLUNG VON KREBS.
SPC Number:

Dates

Filing date:
24/11/2017
Grant date:
20/03/2024
EP Publication Date:
02/10/2019
PCT Publication Date:
31/05/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2024
EP B1 Publication Date:
20/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/11/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2024
 
 

Name:
Translational Drug Development, LLC
Address:
13208 East Shea Boulevard Suite 100, Scottsdale, Arizona 85259, United States (US)

Inventor

1

Name:
WANG, Tong
Address:
United States (US)

2

Name:
GONZALES, Paul
Address:
United States (US)

3

Name:
GATELY, Stephen
Address:
United States (US)

Priority

Priority Number:
201662426031 P
Priority Date:
23/11/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4184; A61K 31/166; A61K 31/4164; C07C 259/10; C07D 235/30; A61K 35/00; A61K 9/08;

Publication

European Patent Bulletin

Issue number:
202412
Publication date:
20/03/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages